(NYSE: NGVT) Ingevity's forecast annual revenue growth rate of 3.27% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Ingevity's revenue in 2025 is $1,281,000,000.On average, 6 Wall Street analysts forecast NGVT's revenue for 2025 to be $46,789,205,632, with the lowest NGVT revenue forecast at $43,588,406,784, and the highest NGVT revenue forecast at $50,493,500,928. On average, 6 Wall Street analysts forecast NGVT's revenue for 2026 to be $48,083,910,784, with the lowest NGVT revenue forecast at $42,761,234,048, and the highest NGVT revenue forecast at $52,219,774,464.
In 2027, NGVT is forecast to generate $51,068,925,440 in revenue, with the lowest revenue forecast at $44,271,723,392 and the highest revenue forecast at $55,168,825,088.